X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$3.01+$0.0100 (+0.33%) on the dayAs of the close; data may be delayed.
XFOR price, last 12 months
Key stats
- Previous close
- $3.00
- Open
- $2.98
- Day range
- $2.97 – $3.08
- 52-week range
- $2.80 – $4.83
- Volume
- 1.8M
- Avg volume (20 days)
- 1.1M
- Market cap
- $298.4M
Performance
1W−15.9%
1M−27.8%
3M−25.1%
6M−30.2%
YTD−24.8%
1Y−15.7%
vs S&P 500, 1Y−32.5 pts
Technicals and fundamentals
About X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $298.4M